Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Modification of proportion sensitivity testing method for ethionamide.

Lakshmi R, Ramachandran R, Devika K, Radhika G, Syam Sundar A, Rahman F, Selvakumar N, Kumar V.

World J Microbiol Biotechnol. 2013 Jun;29(6):1117-9. doi: 10.1007/s11274-013-1255-y. Epub 2013 Jan 12.

PMID:
23315266
[PubMed - indexed for MEDLINE]
2.

Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide.

Huang TS, Lee SS, Tu HZ, Huang WK, Chen YS, Huang CK, Wann SR, Lin HH, Liu YC.

J Antimicrob Chemother. 2004 Apr;53(4):600-3. Epub 2004 Feb 18.

PMID:
14973155
[PubMed - indexed for MEDLINE]
Free Article
3.

Consistency of standard laboratory strain Mycobacterium tuberculosis H 37 Rv with ethionamide susceptibility testing.

Lakshmi R, Kumar V, Rahman F, Ramachandran R.

Indian J Med Res. 2012 May;135(5):672-4.

PMID:
22771598
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex.

Lin SY, Desmond E, Bonato D, Gross W, Siddiqi S.

J Clin Microbiol. 2009 Nov;47(11):3630-4. doi: 10.1128/JCM.00803-09. Epub 2009 Sep 9.

PMID:
19741086
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Testing susceptibility of multidrug-resistant Mycobacterium tuberculosis to second-line drugs by use of blood agar.

Satana D, Coban AY, Uzun M.

J Clin Microbiol. 2010 Nov;48(11):4291-3. doi: 10.1128/JCM.00688-10. Epub 2010 Sep 8.

PMID:
20826642
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.

Umubyeyi A, Rigouts L, Shamputa IC, Dediste A, Struelens M, Portaels F.

Int J Infect Dis. 2008 Mar;12(2):152-6. Epub 2007 Oct 18.

PMID:
17950021
[PubMed - indexed for MEDLINE]
Free Article
7.

Standardization of first and second-line antitubercular susceptibility testing using BacT Alert 3D system: a report from a tertiary care centre in India.

Nair D, Capoor MR, Rawat D, Srivastava L, Aggarwal P.

Braz J Infect Dis. 2009 Dec;13(6):422-6.

PMID:
20464333
[PubMed - indexed for MEDLINE]
Free Article
8.

Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance.

Kam KM, Sloutsky A, Yip CW, Bulled N, Seung KJ, Zignol M, Espinal M, Kim SJ.

Int J Tuberc Lung Dis. 2010 Mar;14(3):282-8.

PMID:
20132618
[PubMed - indexed for MEDLINE]
9.

[The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].

Kayali R, Cöplü N, Ceyhan I, Ocak F, Citil BE, Esen B.

Mikrobiyol Bul. 2006 Jan-Apr;40(1-2):1-7. Turkish.

PMID:
16775950
[PubMed - indexed for MEDLINE]
10.

Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.

Lee H, Cho SN, Bang HE, Lee JH, Bai GH, Kim SJ, Kim JD.

Int J Tuberc Lung Dis. 2000 May;4(5):441-7.

PMID:
10815738
[PubMed - indexed for MEDLINE]
11.
12.

Comparison of the susceptibility testing of clinical isolates of Mycobacterium tuberculosis by the XTT colorimetric method and the NCCLS standards method.

De Logu A, Pellerano ML, Sanna A, Pusceddu MC, Uda P, Saddi B.

Int J Antimicrob Agents. 2003 Mar;21(3):244-50.

PMID:
12636986
[PubMed - indexed for MEDLINE]
13.

Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.

de Kantor IN, Barrera L.

Medicina (B Aires). 2007;67(3):231-7.

PMID:
17628909
[PubMed - indexed for MEDLINE]
14.

Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs.

Toungoussova OS, Mariandyshev AO, Bjune G, Caugant DA, Sandven P.

Eur J Clin Microbiol Infect Dis. 2005 Mar;24(3):202-6.

PMID:
15742171
[PubMed - indexed for MEDLINE]
15.

Rifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugs.

Kurbatova EV, Cavanaugh JS, Shah NS, Wright A, Kim H, Metchock B, Van Deun A, Barrera L, Boulahbal F, Richter E, Martín-Casabona N, Arias F, Zemanova I, Drobniewski F, Santos Silva A, Coulter C, Lumb R, Cegielski JP.

Int J Tuberc Lung Dis. 2012;16(3):355-7. doi: 10.5588/ijtld.11.0542.

PMID:
22640449
[PubMed - indexed for MEDLINE]
16.

New generation methods for drug susceptibility testing for tuberculosis.

Katoch VM.

Indian J Tuberc. 2008 Apr;55(2):61-3. No abstract available.

PMID:
18516820
[PubMed - indexed for MEDLINE]
18.

Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method.

Martin A, Camacho M, Portaels F, Palomino JC.

Antimicrob Agents Chemother. 2003 Nov;47(11):3616-9.

PMID:
14576129
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Evaluation of BACTEC MGIT 960 system for the second-line drugs susceptibility testing of Mycobacterium tuberculosis in China.

Zhao LL, Xia Q, Lin N, Liu B, Zhao XQ, Liu Z, Wan KL.

J Microbiol Methods. 2012 Oct;91(1):212-4. doi: 10.1016/j.mimet.2012.06.010. Epub 2012 Jul 2.

PMID:
22766324
[PubMed - indexed for MEDLINE]
20.

Polymorphisms associated with resistance and cross-resistance to aminoglycosides and capreomycin in Mycobacterium tuberculosis isolates from South Korean Patients with drug-resistant tuberculosis.

Via LE, Cho SN, Hwang S, Bang H, Park SK, Kang HS, Jeon D, Min SY, Oh T, Kim Y, Kim YM, Rajan V, Wong SY, Shamputa IC, Carroll M, Goldfeder L, Lee SA, Holland SM, Eum S, Lee H, Barry CE 3rd.

J Clin Microbiol. 2010 Feb;48(2):402-11. doi: 10.1128/JCM.01476-09. Epub 2009 Dec 23.

PMID:
20032248
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk